Publications

Bruxelles Woluwe

Selected publications

  1. Frédérick R.
    Inhibition of the kynurenine pathway of tryptophan metabolism in targeting the broadly pathogenic kynurenine pathway. (pp 393-406) Springer, Switzerland.
  2. Serra S., Moineaux L., Vancraeynest C., Masereel B., Wouters J., Pochet L., Frédérick R.
    Thiosemicarbazide, a fragment with promising indolamine-2,3-dioxygenase (IDO) inhibition properties.
    Eur. J. Med. Chem. (2014), 82: 96-105.
  3. Pilotte L., Larrieu P., Stroobant V., Colau D., Dolusić E., Frédérick R., De Plaen E., Uyttenhove C., Wouters J., Masereel B., Van den Eynde B.
    Reversal of tumoral immune resistance by inhibition of tryptophan 2,3-dioxygenase.
    Proc. Natl. Acad. Sci. USA (2012), 109:2497-502.
  4. Dolusić E., Larrieu P., Moineaux L., Stroobant V., Pilotte L., Colau D., Pochet L., Van den Eynde B., Masereel B., Wouters J., Frédérick R.
    Tryptophan 2,3-dioxygenase (TDO) inhibitors. 3-(2-(pyridyl)ethenyl)indoles as potential anticancer immunomodulators.
    J. Med. Chem. (2011), 54: 5320-5334.
  5. Frédérick R., Denny W.
    Phosphoinositide-3-kinases (PI3Ks): combined comparative modelling and 3D-QSAR to rationalize the inhibition of p110alpha.
    J. Chem. Inf. Model. (2008), 48: 629-638.